Recurrent Brain Tumors Show Different Genetic Changes by Type [Reading Science]
International team analyzes genomic data from 183 patients before and after treatment
Chromosomal changes prominent in astrocytomas, new mutations in oligodendrogliomas
It has been found that brain tumors with the same genetic mutation undergo different genomic changes as they progress and recur, depending on the tumor type. The findings are expected to provide important clues for understanding why intractable brain tumors recur and developing treatment strategies tailored to each tumor type.
Seoul National University's Advanced Institute of Convergence Technology said on November 6 that an international research team, including Professor Baek Seonha of Seoul National University's College of Medicine and Seoul National University Hospital's Department of Neurosurgery, and Dr. Moon Hyoeun, had identified patterns of genomic changes in different types of IDH-mutant glioma. The results were published in the international journal Nature on October 14.
Genomic changes vary by brain tumor type. An international research team analyzed tumor genomes before and after treatment in 183 patients with IDH-mutant gliomas. DNA copy-number changes, such as gene amplification and deletion, were more prominent in astrocytomas, while new gene mutations were relatively more prominent in oligodendrogliomas. Image provided by Nature.
View original imageResearchers from Yale School of Medicine, the Jackson Laboratory for Genomic Medicine and the University of Connecticut in the United States also participated in the study.
IDH-mutant gliomas are brain tumors in which mutations occur in the IDH1 or IDH2 genes, which are involved in cellular metabolism. They are mainly classified as astrocytomas or oligodendrogliomas. Both types are difficult to treat because they can recur even after surgery, chemotherapy and radiation therapy.
The research team analyzed tumor genomic data collected before and after treatment from 183 patients by the Glioma Longitudinal Analysis Consortium (GLASS), an international research collaboration. Using whole-genome analysis, which examines all of a tumor's DNA, and whole-exome analysis, which examines the regions of genes that produce proteins, the team tracked the genetic changes tumors undergo during treatment.
The analysis found that the two types of tumors evolve in different ways. In astrocytomas, chromosomal copy-number changes, such as the amplification of specific cancer-related genes, and abnormalities in chromosome number were prominent. By contrast, oligodendrogliomas were characterized by the emergence of new gene mutations involved in tumor progression.
Joint research team. From left: Baek Seonha, professor at Seoul National University's Institute of Convergence Science and Technology; Dr. Moon Hyoeun; Roel Verhaak, professor at Yale University; and Frederick Van, professor at Jackson Laboratory for Genomic Medicine and the University of Connecticut. Photo provided by Seoul National University.
View original imageThe findings show that even gliomas with the same IDH mutation may involve different genetic changes during recurrence. The research team expects these differences to help inform the development of targeted therapies and personalized treatment strategies for each tumor type. However, this study analyzed patterns of genomic changes and did not clinically demonstrate the effectiveness of a new treatment.
In June, the research team also published findings in Nature showing that genetic changes and the tumor microenvironment both contribute to the progression and recurrence of IDH-mutant gliomas. The latest study builds on that earlier work by providing a detailed analysis of differences in genomic changes across tumor types.
Hot Picks Today
"Two Spend 500,000 Won in a Flash, Yet Wait Two Hours?" ... 'Dreamland' Shunned by Kids and Foreign Tourists
- The Era of Getting 200 Million Won After 30 Years Is Over... A Japanese Bank's "Perpetual Department Head" Who Just Clocked In Cries Out
- Spain Hit by Its Worst Tragedy... Lee Kangin, Moreno and Real Madrid Join Soccer World in Mourning
- They Said, “Make It Your Home for Life” - Then Suddenly Kicked 200 Passengers Off... What Happened to the Around-the-World Cruise?
- "130 Rice Bowls Sold Out in a Day"... 'Unfiltered Face' Adds 8 Million Won to Night Market Sales: China's Bungeunwoo
Professor Baek said, "This study comprehensively identified how IDH-mutant gliomas show different patterns of genomic change by tumor type during treatment. We hope it will help improve treatment prospects for patients with intractable brain tumors by contributing to the development of targeted and personalized treatment strategies that take into account tumor characteristics and how they change over time."
© The Asia Business Daily. All rights reserved. Unauthorized AI training and use prohibited.